ID 113393
Title Alternative
Class 1 HDAC-specific inhibition augments but HDAC6 inhibition mitigates CD38 upregulation in myeloma cells by interferon-α and all-trans retinoic acid
Author
Bat‐Erdene, Ariunzaya Tokushima University
Oda, Asuka Tokushima University
Iwasa, Masami Tokushima University
Ashtar, Mohannad Tokushima University
Udaka, Kengo Tokushima University
Keywords
multiple myeloma
HDAC inhibition
CD38
interferon‐α
ATRA
Content Type
Journal Article
Journal Title
British Journal of Haematology
ISSN
00071048
13652141
NCID
AA00574570
Publisher
John Wiley & Sons, Inc.
Volume
185
Issue
5
Start Page
969
End Page
974
Published Date
2018-11-26
Remark
This is the peer reviewed version of the following article: Bat‐Erdene, A. , Nakamura, S. , Oda, A. , Iwasa, M. , Teramachi, J. , Ashtar, M. , Harada, T. , Miki, H. , Tenshin, H. , Hiasa, M. , Fujii, S. , Sogabe, K. , Oura, M. , Udaka, K. , Kagawa, K. , Yoshida, S. , Aihara, K. , Kurahashi, K. , Endo, I. and Abe, M. (2019), Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA. Br J Haematol, 185: 969-974. doi:10.1111/bjh.15673. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

論文本文は2019-11-26以降公開予定
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
language
eng
TextVersion
その他
departments
Medical Sciences
Oral Sciences
University Hospital